Jun 29, 2017 Oncolytics® Biotech Inc. Appoints Andrew de Guttadauro, President of Oncolytics Biotech (U.S.) Inc.
May 23, 2017 Oncolytics Biotech® Inc. Announces Participation in World Immunotherapy Congress USA 2017
May 17, 2017 Oncolytics Biotech® Announces ASCO Abstracts and Preliminary Data for Studies in Pancreatic and Prostate Cancers
May 8, 2017 Oncolytics Biotech® Inc. Announces FDA Fast Track Designation for REOLYSIN® in Metastatic Breast Cancer
May 4, 2017 Oncolytics Biotech® Inc. Announces Voting Results from its Annual Meeting of Shareholders
